Determination of editors at the novel A-to-I editing positions
- PMID: 18407364
- DOI: 10.1016/j.neures.2008.02.009
Determination of editors at the novel A-to-I editing positions
Abstract
A-to-I RNA editing modifies a variety of biologically important mRNAs, and is specifically catalyzed by either adenosine deaminase acting on RNA type 1 (ADAR1) or type 2 (ADAR2) in mammals including human. Recently several novel A-to-I editing sites were identified in mRNAs abundantly expressed in mammalian organs by means of computational genomic analysis, but which enzyme catalyzes these editing sites has not been determined. Using RNA interference (RNAi) knockdowns, we found that cytoplasmic fragile X mental retardation protein interacting protein 2 (CYFIP2) mRNA had an ADAR2-mediated editing position and bladder cancer associated protein (BLCAP) mRNA had an ADAR1-mediated editing position. In addition, we found that ADAR2 forms a complex with mRNAs with ADAR2-mediated editing positions including GluR2, kv1.1 and CYFIP2 mRNAs, particularly when the editing sites were edited in human cerebellum by means of immunoprecipitation (IP) method. CYFIP2 mRNA was ubiquitously expressed in human tissues with variable extents of K/E site editing. Because ADAR2 underactivity may be a causative molecular change of death of motor neurons in sporadic amyotrophic lateral sclerosis (ALS), this newly identified ADAR2-mediated editing position may become a useful tool for ALS research.
Similar articles
-
Newly identified ADAR-mediated A-to-I editing positions as a tool for ALS research.RNA Biol. 2008 Oct-Dec;5(4):193-7. doi: 10.4161/rna.6925. Epub 2008 Oct 5. RNA Biol. 2008. PMID: 18971634
-
Novel etiological and therapeutic strategies for neurodiseases: RNA editing enzyme abnormality in sporadic amyotrophic lateral sclerosis.J Pharmacol Sci. 2010;113(1):9-13. doi: 10.1254/jphs.09r21fm. Epub 2010 Apr 16. J Pharmacol Sci. 2010. PMID: 20424386 Review.
-
Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.Neurosci Res. 2009 Jul;64(3):251-8. doi: 10.1016/j.neures.2009.03.009. Epub 2009 Mar 25. Neurosci Res. 2009. PMID: 19447293
-
Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.Neurobiol Dis. 2012 Mar;45(3):1121-8. doi: 10.1016/j.nbd.2011.12.033. Epub 2011 Dec 28. Neurobiol Dis. 2012. PMID: 22226999
-
AMPA receptor-mediated neuronal death in sporadic ALS.Neuropathology. 2010 Apr;30(2):182-8. doi: 10.1111/j.1440-1789.2009.01090.x. Epub 2010 Jan 19. Neuropathology. 2010. PMID: 20102521 Review.
Cited by
-
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis.Mol Brain. 2013 Jul 8;6:31. doi: 10.1186/1756-6606-6-31. Mol Brain. 2013. PMID: 23835137 Free PMC article.
-
Human BLCAP transcript: new editing events in normal and cancerous tissues.Int J Cancer. 2010 Jul 1;127(1):127-37. doi: 10.1002/ijc.25022. Int J Cancer. 2010. PMID: 19908260 Free PMC article.
-
Antisense oligonucleotide therapy for the treatment of C9ORF72 ALS/FTD diseases.Mol Neurobiol. 2014 Dec;50(3):721-32. doi: 10.1007/s12035-014-8724-7. Epub 2014 May 9. Mol Neurobiol. 2014. PMID: 24809691 Review.
-
A strategy for developing a hammerhead ribozyme for selective RNA cleavage depending on substitutional RNA editing.RNA. 2012 Sep;18(9):1735-44. doi: 10.1261/rna.033399.112. Epub 2012 Jul 13. RNA. 2012. PMID: 22798264 Free PMC article.
-
RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.PLoS Genet. 2021 May 13;17(5):e1009516. doi: 10.1371/journal.pgen.1009516. eCollection 2021 May. PLoS Genet. 2021. PMID: 33983932 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous